-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to encourage pharmaceutical companies to develop drugs for the treatment of rare diseases and improve the efficiency and quality of clinical research and development, our center has organized the drafting of the "Rules for Clinical Research of Rare Disease Drugs (Draft for Comment)", which is now open for comments
.
We welcome valuable comments and suggestions from all walks of life, and please give us feedback in time
The time limit for soliciting opinions is 1 month from the date of publication
Please send your feedback to the mailbox: Heng Mingli hengml@cde.
Thank you for your participation and great support
Drug Evaluation Center of the State Drug Administration
November 18, 2021
Appendix:
1 Drafting instructions for "Statistics Guiding Principles for Clinical Research of Rare Disease Drugs (Draft for Solicitation of Comments)".
1 Drafting instructions for "Statistics Guiding Principles for Clinical Research of Rare Disease Drugs (Draft for Solicitation of Comments)".
2 "Guiding Principles of Statistics for Clinical Research of Rare Disease Drugs (Draft for Solicitation of Comments)".
3 "Guiding Principles of Statistics for Clinical Research of Rare Disease Drugs (Draft for Solicitation of Comments)" feedback form for soliciting opinions.
docx